Showing 1 to 9 of 9 results
Oral Herpes Virus Implicated in Multiple Sclerosis Development
Researchers found that mice lacking the protein optineurin, crucial for controlling oral herpes (HSV-1) infections, developed MS-like symptoms after infection, suggesting a possible link between HSV-1 and multiple sclerosis, affecting nearly half of all adults.
Oral Herpes Virus Implicated in Multiple Sclerosis Development
Researchers found that mice lacking the protein optineurin, crucial for controlling oral herpes (HSV-1) infections, developed MS-like symptoms after infection, suggesting a possible link between HSV-1 and multiple sclerosis, affecting nearly half of all adults.
Progress
20% Bias Score
HSV-1 and Alzheimer's Disease: A Correlation Study
A study of 340,000 patients over 50 in the US found an 80 percent increased relative risk of Alzheimer's disease among those with herpes simplex virus type 1 (HSV-1), while antiviral therapy reduced the risk by 17 percent; however, the study does not establish causation.
HSV-1 and Alzheimer's Disease: A Correlation Study
A study of 340,000 patients over 50 in the US found an 80 percent increased relative risk of Alzheimer's disease among those with herpes simplex virus type 1 (HSV-1), while antiviral therapy reduced the risk by 17 percent; however, the study does not establish causation.
Progress
16% Bias Score
HSV-1 Infection Linked to Increased Alzheimer's Risk, Antivirals Show Potential Protective Effect
A study of 344,628 individuals over 50, diagnosed with Alzheimer's between 2006 and 2021, revealed an 80% increased Alzheimer's risk for those with HSV-1, but antiviral use reduced this risk by 17%.
HSV-1 Infection Linked to Increased Alzheimer's Risk, Antivirals Show Potential Protective Effect
A study of 344,628 individuals over 50, diagnosed with Alzheimer's between 2006 and 2021, revealed an 80% increased Alzheimer's risk for those with HSV-1, but antiviral use reduced this risk by 17%.
Progress
52% Bias Score
Genital Herpes: 846 Million Infections, Rising Rates, and the Urgent Need for New Treatments
Globally, 846 million people aged 15-49 have genital herpes, with 42 million new infections yearly; rates are rising for HSV-1 in developed nations due to delayed childhood exposure, while dropping in sub-Saharan Africa due to HIV/AIDS interventions.
Genital Herpes: 846 Million Infections, Rising Rates, and the Urgent Need for New Treatments
Globally, 846 million people aged 15-49 have genital herpes, with 42 million new infections yearly; rates are rising for HSV-1 in developed nations due to delayed childhood exposure, while dropping in sub-Saharan Africa due to HIV/AIDS interventions.
Progress
24% Bias Score
WHO: 1 in 5 under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
WHO estimates reveal that 1 in 5 people under 50 globally have genital herpes, with HSV-2 causing the vast majority of the 204.6 million genital ulcer cases in 2020; this necessitates vaccine development to address the $35 billion annual economic burden and the increased HIV transmission risk.
WHO: 1 in 5 under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
WHO estimates reveal that 1 in 5 people under 50 globally have genital herpes, with HSV-2 causing the vast majority of the 204.6 million genital ulcer cases in 2020; this necessitates vaccine development to address the $35 billion annual economic burden and the increased HIV transmission risk.
Progress
36% Bias Score
Oral Herpes: Transmission, Symptoms, and Treatment
Oral herpes, a common infection caused by HSV-1, is often contracted in the twenties. It spreads through close contact with sores or contaminated objects, and symptoms, ranging from mild to severe, usually resolve within two weeks, though antiviral medication can help.
Oral Herpes: Transmission, Symptoms, and Treatment
Oral herpes, a common infection caused by HSV-1, is often contracted in the twenties. It spreads through close contact with sores or contaminated objects, and symptoms, ranging from mild to severe, usually resolve within two weeks, though antiviral medication can help.
Progress
8% Bias Score
Cold Sores Linked to Increased Alzheimer's Risk
A new study of 344,628 case-control pairs found an 80% higher chance of an HSV-1 diagnosis in those with Alzheimer's; anti-herpetic medication reduced Alzheimer's risk by 17%, suggesting a potential role for viral prevention in public health.
Cold Sores Linked to Increased Alzheimer's Risk
A new study of 344,628 case-control pairs found an 80% higher chance of an HSV-1 diagnosis in those with Alzheimer's; anti-herpetic medication reduced Alzheimer's risk by 17%, suggesting a potential role for viral prevention in public health.
Progress
48% Bias Score
Head Injuries May Reactivate Brain Viruses, Triggering Alzheimer's: Lab Study
Laboratory research suggests that head injuries may reactivate dormant herpes viruses (like HSV-1) in the brain, triggering inflammation and potentially leading to Alzheimer's disease, due to beta-amyloid plaque buildup and tau protein formation; this was demonstrated in a model brain.
Head Injuries May Reactivate Brain Viruses, Triggering Alzheimer's: Lab Study
Laboratory research suggests that head injuries may reactivate dormant herpes viruses (like HSV-1) in the brain, triggering inflammation and potentially leading to Alzheimer's disease, due to beta-amyloid plaque buildup and tau protein formation; this was demonstrated in a model brain.
Progress
36% Bias Score
WHO Report: One in Five Under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
A new WHO report reveals that one in five people under 50 globally have genital herpes, with HSV-2 being the primary cause, resulting in a significant global economic burden of $35 billion annually and highlighting the urgent need for a vaccine.
WHO Report: One in Five Under 50 Have Genital Herpes, Highlighting Urgent Need for Vaccine
A new WHO report reveals that one in five people under 50 globally have genital herpes, with HSV-2 being the primary cause, resulting in a significant global economic burden of $35 billion annually and highlighting the urgent need for a vaccine.
Progress
36% Bias Score
Showing 1 to 9 of 9 results